Dr. Pradhan is the Director for the Center of Clinical Pharmacology at Washington University School of Medicine and the University of Health Sciences and Pharmacy in St. Louis. Her lab investigates novel therapies for migraine, and she identified the delta opioid receptor as a promising target for this disorder. Ongoing studies in her lab are focused on the differential role of mu and delta opioid receptors in headache. Additionally, the lab focuses on identifying the molecular mechanisms that contribute to migraine chronicity, as well as overlapping mechanisms between migraine and neuropsychiatric conditions.

Dr. Elizabeth Seng, PhD, is an Associate Professor of Health Psychology at Yeshiva University and Research Associate Professor of Neurology at Albert Einstein College of Medicine. Her research aims to harness the power of behavior change to improve the lives of people with migraine and headache disorders through individual and societal interventions.

Catherine Chong, PhD is a neuroimaging scientist who uses structural and functional Magnetic Resonance Imaging techniques to elucidate the pathomechanism underlying headache disorders. It is her goal to identify clinical and neuroimaging biomarkers that predict headache recovery and treatment response in patients with migraine and post-traumatic headache.

Edwin S. Lowe Professor and Vice Chair of Neurology Professor of Epidemiology and Population Health Professor of Psychiatry and Behavioral Sciences Director, Montefiore Headache Center Director, Division of Cognitive Aging and Dementia Albert Einstein College of Medicine

Dr Andy Russo is a Professor of Molecular Physiology, Biophysics and Neurology at the University of Iowa. He received his PhD in Biochemistry from UC Berkeley and did postdoctoral training at UCSD on the neuropeptide CGRP. The focus of Dr Russo’s research is the molecular basis of migraine. He is currently using mouse genetic models to study how CGRP contributes to the pain and altered sensory processing of migraine. The overall goal of his studies is to develop effective diagnostic and therapeutic strategies for migraine and post-traumatic headache.

Dr. Rebecca Erwin Wells is Professor in Neurology at Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist. She founded and directs their Comprehensive Headache Program since 2012. She graduated from UNC-Chapel Hill, East Carolina-Brody School of Medicine, Harvard School of Public Health, and completed Neurology residency from University of Virginia. She completed Harvard fellowships in both Integrative Medicine research and Headache Medicine. Dr. Wells is President of the Southern Headache Society and on the AHS Board of Directors. She received the AHS "Above and Beyond Award" for her service as Co-Chair of the AHS Diversity, Equity, and Inclusion Taskforce. She won the AHS Early Career Lecture Award and the American Academy of Neurology’s Wolff-Graham award for recognition of her outstanding achievements in headache/facial pain research. She is a Fellow of the AHS and of the AAN. Her NIH funded research investigates Integrative Medicine treatments for migraine.

Dr. Gregory Dussor is Professor and Chair of the Department of Neuroscience at the University of Texas at Dallas. His work focuses on mechanisms of activation and sensitization of peripheral nociceptors innervating the cranial meninges with a goal of understanding how these neurons contribute to the pain phase of migraine attacks. Using several preclinical models, his group has identified and studied numerous targets within this afferent nociceptive system. More recently, his work has focused on mechanisms that may lead to the higher prevalence of migraine in females. He has published over 120 peer-reviewed research articles, he has served on the editorial boards of Pain, Pain Reports, Molecular Pain, the Journal of Pain, Headache, the Journal of Headache and Pain, and the Journal of Neuroscience, and he is on administrative committees for the US and International Associations for the Study of Pain (USASP and IASP) and the American Headache Society.

Dr. Yohannes W. Woldeamanuel, M.D., is an assistant professor in neurology at the Division of Headache in the Department of Neurology at Mayo Clinic Arizona. He is the principal investigator of an NINDS-funded study focused on developing and determining the efficacy and underlying mechanisms of circadian-based interventions for migraine. Additionally, he has obtained NCI funding to determine the efficacy of a sleep behavioral intervention to reduce headache burden in cancer survivors from a multi-center clinical trial, as well as to identify patient phenotypes and response predictors. He serves as an editorial board member for The Journal of Headache and Pain and as a peer reviewer for neurology and headache scientific journals. More information about his bio is available at orcid.org/0000-0003-4879-6098.

Jayme Waite, B.S.E is a research assistant in Levi Sower's lab within the University of Iowa and Department of Veteran Affairs. Her current research focuses on the role of amylin and the amylin receptor in gastrointestinal adverse effects.

My name is Jhoan Aguilar, I am fourth year PhD student in Amynah Pradhan's lab at Washington University in Saint Louis. I am currently investigating the role of the extracellular matrix in pain development.

My name is Mandee Schaub, MS and I am a PhD Student at the University of Texas at Dallas under the mentorship of Dr. Gregory Dussor. As a severe continuous headache and migraine patient, I know firsthand the impact of battling headache disorders, the challenges associated with current treatments, and needs for headache patients. With these experiences and an irrefutable passion for decreasing the burden of migraine on the general public, I have begun my PhD training in the lab of Dr. Dussor, where we study the mechanism of migraine and explore therapeutic targets for treatment. Upon completion of my training, I plan to run an independent migraine research lab that uses electrophysiological techniques to contribute to the understanding of migraine disease, and improving therapeutic options for patients.

Dr. Gregory Dussor is Professor and Chair of the Department of Neuroscience at the University of Texas at Dallas. His work focuses on mechanisms of activation and sensitization of peripheral nociceptors innervating the cranial meninges with a goal of understanding how these neurons contribute to the pain phase of migraine attacks. Using several preclinical models, his group has identified and studied numerous targets within this afferent nociceptive system. More recently, his work has focused on mechanisms that may lead to the higher prevalence of migraine in females. He has published over 120 peer-reviewed research articles, he has served on the editorial boards of Pain, Pain Reports, Molecular Pain, the Journal of Pain, Headache, the Journal of Headache and Pain, and the Journal of Neuroscience, and he is on administrative committees for the US and International Associations for the Study of Pain (USASP and IASP) and the American Headache Society.

Andrea Harriott, MD PhD is a Neurologist at Massachusetts General Hospital and an Assistant Professor at Harvard Medical School. Dr. Harriott has dual subspecialty training in Vascular Neurology and Headache Medicine, completing two fellowships at Massachusetts General Hospital and The John R. Graham Headache Center. Dr. Harriott’s clinical research interests center on the association between migraine and vascular disease in young women. Dr. Harriott’s basic science research uses an optogenetic technique to elicit the electrical events responsible for migraine aura in rodents as a non-invasive model of episodic and chronic migraine aura to discover sex and gonadal hormone mechanisms of migraine pain and the role of the hypothalamus in mediating sex differences in migraine pathobiology.

Dr. Elizabeth Seng, PhD, is an Associate Professor of Health Psychology at Yeshiva University and Research Associate Professor of Neurology at Albert Einstein College of Medicine. Her research aims to harness the power of behavior change to improve the lives of people with migraine and headache disorders through individual and societal interventions.

Dr. Gregory Dussor is Professor and Chair of the Department of Neuroscience at the University of Texas at Dallas. His work focuses on mechanisms of activation and sensitization of peripheral nociceptors innervating the cranial meninges with a goal of understanding how these neurons contribute to the pain phase of migraine attacks. Using several preclinical models, his group has identified and studied numerous targets within this afferent nociceptive system. More recently, his work has focused on mechanisms that may lead to the higher prevalence of migraine in females. He has published over 120 peer-reviewed research articles, he has served on the editorial boards of Pain, Pain Reports, Molecular Pain, the Journal of Pain, Headache, the Journal of Headache and Pain, and the Journal of Neuroscience, and he is on administrative committees for the US and International Associations for the Study of Pain (USASP and IASP) and the American Headache Society.

Dr. Pradhan is the Director for the Center of Clinical Pharmacology at Washington University School of Medicine and the University of Health Sciences and Pharmacy in St. Louis. Her lab investigates novel therapies for migraine, and she identified the delta opioid receptor as a promising target for this disorder. Ongoing studies in her lab are focused on the differential role of mu and delta opioid receptors in headache. Additionally, the lab focuses on identifying the molecular mechanisms that contribute to migraine chronicity, as well as overlapping mechanisms between migraine and neuropsychiatric conditions.